The consolidated whistleblower lawsuit accuses the pharmacy chain of helping to fuel the opioid crisis, by systematically pressuring its pharmacists to fill prescriptions, including controlled substances,

Walgreens shares sank Tuesday, the first day of trading since the Department of Justice announced a lawsuit accusing the pharmacy chain of dispensing "millions of unlawful prescriptions" with no legitimate medical purpose.

Walgreens skimped on compliance and filled millions of prescriptions for narcotics that weren't medically necessary, the Department of Justice alleged in a complaint against the company, first brought by four whistleblowers.

The Department of Justice (DOJ) filed a lawsuit late last week against Walgreens alleging the company and its subsidiaries unlawfully dispensed and sought reimbursement for “millions” of prescripti | The pharmacy chain dispensed “dangerous and excessive quantities,

Walgreens Boots Alliance Inc. tumbled after the US sued the company last week claiming its pharmacists filled millions of prescriptions that lacked a legitimate medical purpose and then sought reimbursements from federal health programs.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) fell by 6% following allegations by the U.S. Justice Department that the pharmacy chain dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (CSA) and the False Claims Act (FCA).

The DOJ is suing Walgreens, claiming pharmacists filled millions of prescriptions that lacked a legitimate medical purpose.

The Justice Department has filed a nationwide lawsuit against Walgreens, alleging the pharmacy chain filled millions of prescriptions without legitimate medical purposes, particularly involving dangerous opioid combinations,